SC 13D

THE SCHEDULE 13D

Company: Carisma Therapeutics Inc.
Filed: November 18, 2022
Accession Number: 0000921895-22-003092

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →

View Document ↗ View on SEC.gov ↗